Liu K[Author] - Search Results

Year	Number of Results
1949	1
1950	1
1951	1
1954	1
1955	1
1957	2
1959	5
1960	1
1961	1
1962	7
1963	5
1964	5
1965	5
1966	2
1967	4
1970	2
1971	4
1972	4
1973	6
1974	6
1975	6
1976	7
1977	7
1978	8
1979	9
1980	15
1981	11
1982	20
1983	18
1984	18
1985	26
1986	40
1987	25
1988	32
1989	30
1990	57
1991	48
1992	49
1993	51
1994	69
1995	104
1996	95
1997	81
1998	100
1999	112
2000	89
2001	88
2002	112
2003	145
2004	176
2005	275
2006	311
2007	336
2008	414
2009	490
2010	555
2011	639
2012	783
2013	866
2014	1054
2015	1231
2016	1325
2017	1428
2018	1567
2019	1786
2020	2179
2021	2536
2022	2913
2023	2960
2024	3296
2025	3872
2026	2747
2027	1

1

What should convince a clinician of disease modification in Alzheimer's disease clinical trials?

Hazan J, Liu KY, Howard R. Hazan J, et al. Among authors: liu ky. Alzheimers Dement. 2026 Jul;22(7):e71643. doi: 10.1002/alz.71643. Alzheimers Dement. 2026. PMID: 42386684 Free PMC article. Review.

2

Association of asthma and COPD with pertussis risk: A systematic review and meta-analysis.

Liu X, Yu X, Yang Q, Tian Z, Guo C, Liu K. Liu X, et al. Among authors: liu k. Respir Med. 2026 Aug-Sep;260:108968. doi: 10.1016/j.rmed.2026.108968. Epub 2026 Jun 17. Respir Med. 2026. PMID: 42309234

3

Chloroplast sunscreening by protein condensates confers high-light tolerance.

Shao N, Chen M, Xu N, Qin Y, Zhao Q, Bock R, Zhou M, Duan G, Yang J, Ji D, Wu D, Wang Y, Lu Y, Lei X, Sun K, Liu K, Liu G, Meng X, Jing Y, Fan X, Zhao Y, Wang B, Yu H, Liu C, Jiang Y, Zhou Z, Li J. Shao N, et al. Among authors: liu k. Cell. 2026 Aug 20;189(17):5182-5197.e9. doi: 10.1016/j.cell.2026.05.042. Epub 2026 Jun 17. Cell. 2026. PMID: 42309053

4

Multi-omics, machine learning, and molecular simulation identify CD44 as a candidate target in endocrine-disrupting chemical-associated thyroid cancer progression.

Hu Y, Liu K, Chen T, He Z, Li S, Hu W, Fu Q, Chen X. Hu Y, et al. Among authors: liu k. Mol Divers. 2026 Aug 30. doi: 10.1007/s11030-026-11721-0. Online ahead of print. Mol Divers. 2026. PMID: 42669107

5

α-ketoglutarate accumulation orchestrates immunosuppressive metabolic remodeling to drive cetuximab resistance in metastatic colorectal cancer.

Zhu Y, Liu K, Chang L, Lu J, Tang H, Zhu Z, Chen Z, Wang X, Xiao J. Zhu Y, et al. Among authors: liu k. Cell Death Dis. 2026 Jun 30. doi: 10.1038/s41419-026-09001-8. Online ahead of print. Cell Death Dis. 2026. PMID: 42380087 Free article.

6

Research progress on the intervention of osteoporosis by Chinese herbal monomers based on the Nrf2/NF-κB/MAPK pathway.

Kou W, Guo C, Lu X, Zhang Z, Liu K, Liu Z, Jiang B, Ma C, Li J, Gao J, Cao L, Zhang X. Kou W, et al. Among authors: liu k. Front Endocrinol (Lausanne). 2026 Jun 24;17:1789264. doi: 10.3389/fendo.2026.1789264. eCollection 2026. Front Endocrinol (Lausanne). 2026. PMID: 42422433 Free PMC article. Review.

7

Graph Neural Network-Assisted Machine Learning for High-Throughput Buried Interfacial Materials Screening in Antisolvent-Free Perovskite Solar Cells.

Liu G, Liu K, Cai H, He B, Liu Y, Yao L, Xu J, Zhang H, Luo J, Liu L, Wu T, Guo Z, Zhao J, Cheng YB, Zhong J. Liu G, et al. Among authors: liu k. ACS Appl Mater Interfaces. 2026 Jul 15;18(27):38190-38202. doi: 10.1021/acsami.6c06418. Epub 2026 Jul 1. ACS Appl Mater Interfaces. 2026. PMID: 42383417

8

AARS2-mediated lactylation of ULK1 promotes autophagy-dependent progression of clear cell renal cell carcinoma.

Zeng X, Zhu Y, Xiao Y, Zhang Z, Chen X, Wei D, Huang C, Liu K, Shi X, Luo F, Wang Q, Lin Z, Xu W, Tan W, Zheng Z. Zeng X, et al. Among authors: liu k. Autophagy. 2026 Jul 8:1-18. doi: 10.1080/15548627.2026.2694660. Online ahead of print. Autophagy. 2026. PMID: 42381569

9

A succinylation-based classifier predicts chemotherapy response in prostate cancer and reveals KAT2A as a therapeutic target.

Dong A, Hu W, Lu Z, Li L, Liu K, Feng S, Xie D. Dong A, et al. Among authors: liu k. Clin Transl Med. 2026 Jul;16(7):e70737. doi: 10.1002/ctm2.70737. Clin Transl Med. 2026. PMID: 42415249 Free PMC article.

10

Induction toripalimab plus chemotherapy sequential concurrent chemoradiotherapy with nimotuzumab followed by toripalimab maintenance in stage IVB hypopharyngeal squamous cell carcinoma: a single-arm phase 2 study.

Geng Z, Chen N, Wei J, Liu K, Gu X, Gou X, Liang R, Wu L, Sui J, Liu L, Meng L, Ma L, Liu T, Yang S, Zhang X. Geng Z, et al. Among authors: liu k. J Immunother Cancer. 2026 Jul 24;14(7):e015325. doi: 10.1136/jitc-2026-015325. J Immunother Cancer. 2026. PMID: 42498484 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

31,701 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

31,701 results

Results by year